Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
European Radiology
Published in: European Radiology 9/2018

01-09-2018 | Head and Neck

MR-based radiomics signature in differentiating ocular adnexal lymphoma from idiopathic orbital inflammation

Authors: Jian Guo, Zhenyu Liu, Chen Shen, Zheng Li, Fei Yan, Jie Tian, Junfang Xian

Published in: European Radiology | Issue 9/2018

Login to get access

Abstract

Objectives

To assess the value of the MR-based radiomics signature in differentiating ocular adnexal lymphoma (OAL) and idiopathic orbital inflammation (IOI).

Methods

One hundred fifty-seven patients with pathology-proven OAL (84 patients) and IOI (73 patients) were divided into primary and validation cohorts. Eight hundred six radiomics features were extracted from morphological MR images. The least absolute shrinkage and selection operator (LASSO) procedure and linear combination were used to select features and build radiomics signature for discriminating OAL from IOI. Discriminating performance was assessed by the area under the receiver-operating characteristic curve (AUC). The predictive results were compared with the assessment of radiologists by chi-square test.

Results

Five radiomics features were included in the radiomics signature, which differentiated OAL from IOI with an AUC of 0.74 and 0.73 in the primary and validation cohorts respectively. There was a significant difference between the classification results of the radiomics signature and those of a radiology resident (p < 0.05), although there was no significant difference between the results of the radiomics signature and those of a more experienced radiologist (p > 0.05).

Conclusions

Radiomics features have the potential to differentiate OAL from IOI.

Key Points

• Clinical and imaging findings of OAL and IOI often overlap, which makes diagnosis difficult.
• Radiomics features can potentially differentiate OAL from IOI non invasively.
• The radiomics signature discriminates OAL from IOI at the same level as an experienced radiologist.
Literature
1.
Rosado MF, Byrne GE, Ding F et al (2006) Ocular adnexal lymphoma: a clinicopathologic study of a large cohort of patients with no evidence for an association with Chlamydia psittaci. Blood 107:467–472CrossRefPubMedPubMedCentral
2.
3.
Shields JA, Shields CL, Scartozzi R (2004) Survey of 1264 patients with orbital tumors and simulating lesions: The 2002 Montgomery Lecture, part 1. Ophthalmology 111:997–1008CrossRefPubMed
4.
Ferreri AJ, Dolcetti R, Du MQ et al (2008) Ocular adnexal MALT lymphoma: an intriguing model for antigen-driven lymphomagenesis and microbial-targeted therapy. Ann Oncol 19:835–846CrossRefPubMed
5.
Woolf DK, Ahmed M, Plowman PN (2012) Primary lymphoma of the ocular adnexa (orbital lymphoma) and primary intraocular lymphoma. Clin Oncol (R Coll Radiol) 24:339–344CrossRef
6.
Kharod SM, Herman MP, Morris CG, Lightsey J, Mendenhall WM, Mendenhall NP (2018) Radiotherapy in the management of orbital lymphoma: a single institution's experience over 4 decades. Am J Clin Oncol 41:100–106PubMed
7.
Shikishima K, Kawai K, Kitahara K (2006) Pathological evaluation of orbital tumours in Japan: analysis of a large case series and 1379 cases reported in the Japanese literature. Clin Exp Ophthalmol 34:239–244CrossRefPubMed
8.
Rubin PA, Foster CS (2004) Etiology and management of idiopathic orbital inflammation. Am J Ophthalmol 138:1041–1043CrossRefPubMed
9.
Swamy BN, McCluskey P, Nemet A et al (2007) Idiopathic orbital inflammatory syndrome: clinical features and treatment outcomes. Br J Ophthalmol 91:1667–1670CrossRefPubMedPubMedCentral
10.
Dagi Glass LR, Freitag SK (2016) Orbital inflammation: Corticosteroids first. Survey of Ophthalmology 61:670–673CrossRefPubMed
11.
Mombaerts I, Rose GE, Garrity JA (2016) Orbital Inflammation: Biopsy first. Survey of Ophthalmology 61:664-669
12.
Cytryn AS, Putterman AM, Schneck GL, Beckman E, Valvassori GE (1997) Predictability of magnetic resonance imaging in differentiation of orbital lymphoma from orbital inflammatory syndrome. Ophthal Plast Reconstr Surg 13:129–134CrossRefPubMed
13.
Haradome K, Haradome H, Usui Y et al (2014) Orbital lymphoproliferative disorders (OLPDs): value of MR imaging for differentiating orbital lymphoma from benign OPLDs. AJNR Am J Neuroradiol 35:1976–1982CrossRefPubMed
14.
Xian J, Zhang Z, Wang Z et al (2010) Value of MR imaging in the differentiation of benign and malignant orbital tumors in adults. Eur Radiol 20:1692–1702CrossRefPubMedPubMedCentral
15.
Warner MA, Weber AL, Jakobiec FA (1996) Benign and malignant tumors of the orbital cavity including the lacrimal gland. Neuroimaging Clin N Am 6:123–142PubMed
16.
Roshdy N, Shahin M, Kishk H et al (2010) MRI in diagnosis of orbital masses. Curr Eye Res 35:986–991CrossRefPubMed
17.
Sullivan TJ, Valenzuela AA (2006) Imaging features of ocular adnexal lymphoproliferative disease. Eye 20:1189–1195CrossRefPubMed
18.
Uehara F, Ohba N (2002) Diagnostic imaging in patients with orbital cellulitis and inflammatory pseudotumor. Int Ophthalmol Clin 42:133–142CrossRefPubMed
19.
Politi LS, Forghani R, Godi C et al (2010) Ocular adnexal lymphoma: diffusion-weighted MR imaging for differential diagnosis and therapeutic monitoring. Radiology 256:565–574CrossRefPubMed
20.
Fatima Z, Ichikawa T, Ishigame K et al (2014) Orbital masses: the usefulness of diffusion-weighted imaging in lesion categorization. Clin Neuroradiol 24:129–134CrossRefPubMed
21.
Kapur R, Sepahdari AR, Mafee MF et al (2009) MR imaging of orbital inflammatory syndrome, orbital cellulitis, and orbital lymphoid lesions: the role of diffusion-weighted imaging. AJNR Am J Neuroradiol 30:64–70CrossRefPubMed
22.
Sepahdari AR, Aakalu VK, Setabutr P, Shiehmorteza M, Naheedy JH, Mafee MF (2010) Indeterminate orbital masses: restricted diffusion at MR imaging with echo-planar diffusion-weighted imaging predicts malignancy. Radiology 256:554–564CrossRefPubMed
23.
Purohit BS, Vargas MI, Ailianou A et al (2016) Orbital tumours and tumour-like lesions: exploring the armamentarium of multiparametric imaging. Insights Imaging 7:43–68CrossRefPubMed
24.
Sun B, Song L, Wang X et al (2017) Lymphoma and inflammation in the orbit: Diagnostic performance with diffusion-weighted imaging and dynamic contrast-enhanced MRI. J Magn Reson Imaging 45:1438–1445CrossRefPubMed
25.
Xu XQ, Hu H, Liu H et al (2017) Benign and malignant orbital lymphoproliferative disorders: differentiating using multiparametric MRI at 3.0T. J Magn Reson Imaging 45:167–176CrossRefPubMed
26.
Lambin P, Riosvelazquez E, Leijenaar RTH et al (2012) Radiomics: Extracting more information from medical images using advanced feature analysis. Eur J Cancer 48:441–446CrossRefPubMedPubMedCentral
27.
28.
Huang Y, Liu Z, He L et al (2016) Radiomics signature: a potential biomarker for the prediction of disease-free survival in early-stage (I or II) non-small cell lung cancer. Radiology 281:947–957CrossRefPubMed
29.
Huang YQ, Liang CH, He L et al (2016) Development and validation of a radiomics nomogram for preoperative prediction of lymph node metastasis in colorectal cancer. J Clin Oncol 34:2157–2164CrossRefPubMed
30.
Parmar C, Leijenaar RT, Grossmann P et al (2015) Radiomic feature clusters and prognostic signatures specific for lung and head & neck cancer. Sci Rep 5:11044CrossRefPubMedPubMedCentral
31.
32.
Nie K, Shi L, Chen Q et al (2016) Rectal cancer: assessment of neoadjuvant chemoradiation outcome based on radiomics of multiparametric MRI. Clin Cancer Res 22:5256–5264CrossRefPubMed
33.
Aerts HJ, Velazquez ER, Leijenaar RT et al (2014) Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun 5:4006CrossRefPubMedPubMedCentral
34.
Bayanati H, Thornhill RE, Souza CA et al (2014) Quantitative CT texture and shape analysis: Can it differentiate benign and malignant mediastinal lymph nodes in patients with primary lung cancer? Eur Radiol 25:480–487CrossRefPubMed
35.
Nie K, Chen JH, Yu HJ, Chu Y, Nalcioglu O, Su MY (2008) Quantitative analysis of lesion morphology and texture features for diagnostic prediction in breast MRI. Acad Radiol 15:1513–1525CrossRefPubMedPubMedCentral
36.
Juntu J, Sijbers J, De Backer S, Rajan J, Van Dyck D (2010) Machine learning study of several classifiers trained with texture analysis features to differentiate benign from malignant soft-tissue tumors in T1-MRI images. J Magn Reson Imaging 31:680–689CrossRefPubMed
37.
Thornhill RE, Golfam M, Sheikh A et al (2014) Differentiation of lipoma from liposarcoma on MRI using texture and shape analysis. Acad Radiol 21:1185–1194CrossRefPubMed
38.
Fruehwald-Pallamar J, Hesselink JR, Mafee MF, Holzer-Fruehwald L, Czerny C, Mayerhoefer ME (2016) Texture-based analysis of 100 MR examinations of head and neck tumors - Is it possible to discriminate between benign and malignant masses in a multicenter trial? Rofo 188:195–202PubMed
39.
40.
Li Z, Mao Y, Li H, Yu G, Wan H, Li B (2015) Differentiating brain metastases from different pathological types of lung cancers using texture analysis of T1 postcontrast MR. Magne Reson Med 76:1410–1419CrossRef
41.
Zhang B, Tian J, Dong D et al (2017) Radiomics features of multiparametric MRI as novel prognostic factors in advanced nasopharyngeal carcinoma. Clin Cancer Res 23:4259–4269CrossRefPubMed
42.
Ganeshan B, Abaleke S, Young RC, Chatwin CR, Miles KA (2010) Texture analysis of non-small cell lung cancer on unenhanced computed tomography: initial evidence for a relationship with tumour glucose metabolism and stage. Cancer Imaging 10:137–143CrossRefPubMedPubMedCentral
43.
Ganeshan B, Miles KA, Young RC, Chatwin CR (2007) In search of biologic correlates for liver texture on portal-phase CT. Acad Radiol 14:1058–1068CrossRefPubMed
44.
Ganeshan B, Skogen K, Pressney I, Coutroubis D, Miles K (2012) Tumour heterogeneity in oesophageal cancer assessed by CT texture analysis: preliminary evidence of an association with tumour metabolism, stage, and survival. Clin Radiol 67:157–164CrossRefPubMed
45.
Ganeshan B, Panayiotou E, Burnand K, Dizdarevic S, Miles K (2012) Tumour heterogeneity in non-small cell lung carcinoma assessed by CT texture analysis: a potential marker of survival. Eur Radiol 22:796–802CrossRefPubMed
46.
Skogen K, Ganeshan B, Good C, Critchley G, Miles K (2013) Measurements of heterogeneity in gliomas on computed tomography relationship to tumour grade. J Neurooncol 111:213–219CrossRefPubMed
47.
Frighetto-Pereira L, Rangayyan RM, Metzner GA (2016) Shape, texture and statistical features for classification of benign and malignant vertebral compression fractures in magnetic resonance images. Computers in Biology & Medicine 73:147–156CrossRef
48.
Woods BJ, Clymer BD, Kurc T et al (2007) Malignant-lesion segmentation using 4D co-occurrence texture analysis applied to dynamic contrast-enhanced magnetic resonance breast image data. J Magn Reson Imaging 25:495–501CrossRefPubMed
49.
Sasaguri K, Takahashi N, Takeuchi M, Carter RE, Leibovich BC, Kawashima A (2016) Differentiation of benign from metastatic adrenal masses in patients with renal cell carcinoma on contrast-enhanced CT. AJR Am J Roentgenol 207:1031–1038CrossRefPubMed
50.
Fruehwald-Pallamar J, Czerny C, Holzer-Fruehwald L et al (2013) Texture-based and diffusion-weighted discrimination of parotid gland lesions on MR images at 3.0 Tesla. NMR Biomed 26:1372–1379CrossRefPubMed
51.
Mueller-Using S, Feldt T, Sarfo FS, Eberhardt KA (2016) Factors associated with performing tuberculosis screening of HIV-positive patients in Ghana: LASSO-based predictor selection in a large public health data set. BMC Public Health 16:563CrossRefPubMedPubMedCentral
52.
Gibbs P, Turnbull LW (2003) Textural analysis of contrast-enhanced MR images of the breast. Magn Reson Med 50:92–98CrossRefPubMed
53.
Xu R, Kido S, Suga K et al (2014) Texture analysis on (18)F-FDG PET/CT images to differentiate malignant and benign bone and soft-tissue lesions. Ann Nucl Med 28:926–935CrossRefPubMed
54.
Way TW, Hadjiiski LM, Sahiner B et al (2006) Computer-aided diagnosis of pulmonary nodules on CT scans: segmentation and classification using 3D active contours. Medical Physics 33:2323–2337CrossRefPubMedPubMedCentral
55.
Sepahdari AR, Politi LS, Aakalu VK, Kim HJ, Razek AA (2014) Diffusion-weighted imaging of orbital masses: multi-institutional data support a 2-ADC threshold model to categorize lesions as benign, malignant, or indeterminate. AJNR Am J Neuroradiol 35:170–175CrossRefPubMed
Metadata
Title
MR-based radiomics signature in differentiating ocular adnexal lymphoma from idiopathic orbital inflammation
Authors
Jian Guo
Zhenyu Liu
Chen Shen
Zheng Li
Fei Yan
Jie Tian
Junfang Xian
Publication date
01-09-2018
Publisher
Springer Berlin Heidelberg
Published in
European Radiology / Issue 9/2018
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-018-5381-7

Other articles of this Issue 9/2018

European Radiology 9/2018 Go to the issue

Neuro

Hippocampal calcification on brain CT: prevalence and risk factors in a cerebrovascular cohort

Neuro

Primary central nervous system lymphoma and atypical glioblastoma: Differentiation using radiomics approach

Computer Applications

Multiregional radiomics features from multiparametric MRI for prediction of MGMT methylation status in glioblastoma multiforme: A multicentre study

Magnetic Resonance

Observer variability of reference tissue selection for relativecerebral blood volume measurements in glioma patients

Oncology

Structured reporting adds clinical value in primary CT staging of diffuse large B-cell lymphoma

Magnetic Resonance

Identification of high-risk plaque features in intracranial atherosclerosis: initial experience using a radiomic approach